Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Tea tree oil

This article was originally published in The Tan Sheet

Executive Summary

FDA tells Rural Industries Research & Development Corporation in February that the agency's review of submissions supporting the use of tea tree oil as a first-aid antiseptic are "not currently in our near-term work plans." FDA said it hopes to complete review of submissions "by the end of this year." RIRDC made a submission to the agency on tea tree oil on behalf of the Australian Tea Tree Industry Association
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS082541

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel